Skip to content
Site de Recherche Intégrée sur le Cancer
Imaging and Longitudinal Investigations to Ameliorate Decision-making
Facebook
Linkedin
Instagram
Youtube
The SIRIC
Presentation
Our missions
Research laboratories
A local environment of excellence
Organization and governance
SIRIC network
Funding for SIRIC
Research
Program 1: PRECIZE
Program 2: DECIPHER
Program 3: SICAJOB
Research platforms and infrastructures
Clinical research
Cohorts and biobanks
Training through research
Cancer and work
The patients and us
Patient associations
Educational resources
News
Archives
Français
The SIRIC
Presentation
Our missions
Research laboratories
A local environment of excellence
Organization and governance
SIRIC network
Funding for SIRIC
Research
Program 1: PRECIZE
Program 2: DECIPHER
Program 3: SICAJOB
Research platforms and infrastructures
Clinical research
Cohorts and biobanks
Training through research
Cancer and work
The patients and us
Patient associations
Educational resources
News
Archives
Français
×
Search
The SIRIC
Presentation
Our missions
Research laboratories
A local environment of excellence
Organization and governance
SIRIC network
Funding for SIRIC
Research
Program 1: PRECIZE
Program 2: DECIPHER
Program 3: SICAJOB
Research platforms and infrastructures
Clinical research
Cohorts and biobanks
Training through research
Cancer and work
The patients and us
Patient associations
Educational resources
News
Archives
Français
The SIRIC
Presentation
Our missions
Research laboratories
A local environment of excellence
Organization and governance
SIRIC network
Funding for SIRIC
Research
Program 1: PRECIZE
Program 2: DECIPHER
Program 3: SICAJOB
Research platforms and infrastructures
Clinical research
Cohorts and biobanks
Training through research
Cancer and work
The patients and us
Patient associations
Educational resources
News
Archives
Français
×
Search
Month:
April 2018
15/04/2018
/
Announcements_1
,
Programme 1 - ThARGET
Public – private partnership: Telix Pharmaceuticals – nuclear oncology, 15 April 2018
The SIRIC is proud to announce the partnership of the Nantes nuclear medicine oncology network with the Australian company Telix
Lire la suite >
Archives 2018-2022
-- Choose an archive
Agenda_1
Annonces_1
Call for projects
Calls for projects_1
Clinical Trails_1
Inter SIRIC_1
Patients and the general public_1
Programme 1 - ThARGET
Programme 2 - PISTER
Programme 2 PISTER
Programme 3 - ReWork-QoL
Publications_1
